企業プロフィール
Precigen 株価・ニュース・カタリスト
- ティッカー:
- PGEN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
7.17 USD (-0.42%)
終値
最終更新: 2026年8月24日
1.38B USD
時価総額
株価変動の要因
As of Aug 24, 2026, PGEN closed down 0.42% at $7.17. No new same-company headline was identified in the current news window.
企業概要
事業概要
Precigen is a biotechnology company focused on gene and cell therapies, as well as engineered biologics. Its platform aims to create novel treatments across several disease areas.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Precigen sits in advanced biotechnology.
ビジネスモデルの特徴
The company depends on platform validation, clinical data, and the ability to convert engineered biology into value.
バイオ業界での位置付け
Precigen is a platform biotech name whose stock reacts to progress in cell and gene therapy programs.
今後のカタリスト
- Precigen’s catalysts are PRGN-2012 and its UltraCAR-T platform, especially any update in recurrent respiratory papillomatosis or other immuno-oncology programs. The company needs to keep proving the platform can produce tangible clinical value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。